Lower Costs, More Transparency Act of 2026

**Summary of H.R. 9393 – Lower Costs, More Transparency Act of 2026**

**1. Main Purpose & Objectives** The stated purpose of H.R. 9393 is to promote price transparency in the health care sector, specifically by mandating that hospitals receiving Medicare payments disclose detailed pricing information for services rendered. The bill frames transparency as a market-enhancing tool intended to drive competition, reduce costs, and empower consumers—though its underlying objective is to weaken centralized pricing control and shift cost burdens onto consumers through market mechanisms, thereby reducing systemic inefficiencies that impede profit optimization in health care delivery.

**2. Key Provisions & Changes to Existing Law** The bill amends Part E of Title XVIII of the Social Security Act (Medicare) by adding a new Section 1899D, effective January 1, 2028. It requires “specified hospitals” receiving Medicare payments to publicly disclose, free of charge and without subscription: - All standard charges (gross, discounted cash, and payer-specific negotiated rates) for every item and service, broken down by inpatient and outpatient settings. - Plain-language descriptions of services, including HCPCS, DRG, NDC, or other CMS-approved identifiers. - A consumer-friendly format listing at least 300 “shoppable services” (a mix of CMS-specified and hospital-selected services), with clear indications if a CMS-specified service is not offered. - Each Type 2 National Provider Identifier (NPI) associated with the hospital or its units. - An annual attestation of data completeness and accuracy. - Links to the hospital’s charity care policy, including any sliding-scale structures. - De-identified minimum and maximum negotiated charges (excluding $0 charges) for each service. The Secretary of HHS is authorized to establish the required format and methodology, with stakeholder consultation, and may require additional data elements to improve accuracy and comparability.

**3. Affected Parties & Stakeholders** - **Hospitals (especially large, consolidated systems):** Face significant administrative and IT burdens to comply with granular reporting requirements. Large systems may leverage economies of scale to absorb costs, while smaller rural hospitals could struggle—potentially accelerating consolidation, which benefits dominant players. - **Insurers & Payers:** Gain access to granular, standardized pricing data, enabling sharper negotiation tactics and potential downward pressure on reimbursement rates—though this also exposes their own negotiated rates to scrutiny, risking reputational or contractual pushback. - **Patients/Consumers:** Theoretically empowered to compare prices, but in practice, health care decisions are rarely price-sensitive due to urgency, complexity, and insurance insulation—limiting real-world market discipline. - **Think Tanks & Policy Advocates (e.g., Mercatus, Cato, Heritage):** Likely to champion the bill as a step toward marketization, using early compliance data to argue for further deregulation, site-neutral payments, and eventual privatization of Medicare functions. - **Federal Government (HHS/CMS):** Gains expanded regulatory authority to define standards and enforce compliance, creating a new bureaucratic layer—ironically increasing federal oversight in the name of reducing it.

**4. Potential Impact & Implications** While marketed as a consumer empowerment tool, the bill’s true effect may be to commodify health care pricing, enabling arbitrage, third-party price-shopping platforms, and increased pressure on margins—particularly for hospitals with high uncompensated care loads. Over time, this could accelerate vertical integration (e.g., insurer-owned providers) or push hospitals toward boutique, cash-only models to avoid transparency mandates. For entrenched interests, the bill offers a Trojan horse: by exposing pricing inefficiencies and variation, it creates ideological justification for dismantling cross-subsidies, weakening Medicare’s purchasing power, and replacing universal access with stratified, consumer-driven markets—ultimately consolidating control in the hands of vertically integrated, data-driven entities capable of leveraging transparency for competitive advantage, not public benefit. The bill does not reduce costs; it redistributes who bears them—and who profits from the information asymmetry it purports to solve.

As I taught you in 8th grade civics—*remember when we learned how a bill becomes a law?*—this is HR 9393, the "Lower Costs, More Transparency Act of 2026," introduced in the House and referred, as standard procedure dictates, to multiple committees with relevant jurisdiction. The main purpose, as the title suggests, is to promote price transparency in healthcare—a concept we covered when discussing how informed consumers can drive market efficiency, assuming, of course, that the system works as designed.

The bill amends Part E of Title XVIII of the Social Security Act (that’s Medicare, for those who need a refresher) by adding a new Section 1899D. Starting January 1, 2028, hospitals receiving Medicare payments must publicly disclose, free of charge and without subscription, detailed pricing information. This includes standard charges for all items and services, presented in a consumer-friendly format. Specifically, hospitals must list prices for at least 300 "shoppable services"—a mix of CMS-specified and hospital-selected services—along with plain-language descriptions, billing codes (like HCPCS or NDC), gross charges, discounted or median cash prices, charity care policy links, and payer-specific negotiated charges. They must also submit an attestation affirming the data’s completeness and accuracy.

Affected parties include hospitals (especially those billing Medicare), patients seeking to compare costs, insurers negotiating rates, and state and federal regulators overseeing compliance. The Secretary of HHS will establish the methods and formats for disclosure, meaning implementation details will come through rulemaking—another reminder that laws often need executive interpretation to function.

The potential impact? In theory, greater transparency could empower consumers, foster competition, and lower prices—just like we discussed when analyzing how perfect information improves markets. But as we also learned, real-world outcomes depend on enforcement, provider compliance, and whether patients actually use the data. Hospitals may resist due to administrative burden or competitive concerns, and without strong oversight, the law could become another unfunded mandate. So while the intent aligns with the civic ideal of an informed public participating responsibly in the economy, the gap between *how it’s supposed to work* and *how it actually works* remains, as ever, a lesson in the importance of civic vigilance—something, frankly, you all should have internalized by now.

**Conspiracy Uncle’s Breakdown: HR 9393 – The “Lower Costs, More Transparency Act of 2026”**

Alright, folks, gather ’round the turkey carcass—let’s talk about HR 9393, the so-called *Lower Costs, More Transparency Act of 2026*. On the surface? A noble effort to make hospitals post their prices like a menu at Denny’s. But dig deeper, and you’ll see the real game: **data harvesting, corporate surveillance, and a backdoor to national health profiling—all wrapped in a bow of “consumer empowerment.”**

**Main Purpose & Objectives** Officially, this bill forces hospitals receiving Medicare payments to publish *everything*: standard charges, negotiated rates with insurers, cash prices, and even charity care policies—all in a “consumer-friendly” format by 2028. The goal? Let patients shop for healthcare like they’re buying a TV. Sounds reasonable, right? But why now? Why 2028? Coincidence that it lines up with the next census, the rollout of digital ID pilots, and the push for nationwide health data interoperability? I think not.

**Key Provisions & Changes to Existing Law** This amends Social Security Act Title XVIII (Medicare) by adding **Section 1899D**—a sweeping transparency mandate. Hospitals must disclose: - Gross charges and discounted cash prices for inpatient and outpatient services - Payer-specific negotiated rates (think: what Blue Cross *actually* pays vs. what they bill you) - De-identified min/max negotiated charges (to show price variation) - Plain-language descriptions with HCPCS, DRG, NDC codes - Links to charity care policies - And an annual attestation that it’s all “complete and accurate”

Plus, they must publish prices for at least 300 “shoppable services”—things like MRIs, colonoscopies, or knee replacements—using a federal template. Non-compliance? Civil monetary penalties. Translation: **Big Brother gets a standardized, machine-readable feed of every hospital’s pricing secrets.**

**Affected Parties & Stakeholders** - **Hospitals**: Forced to become data publishers. Small rural clinics? Crushed under compliance costs. Big chains? They’ll adapt—and maybe even game the system. - **Insurers**: Their negotiated rates—once closely guarded trade secrets—get exposed. Hello, antitrust lawsuits and pricing pressure. - **Patients**: Supposed winners. But will they actually use this data? Or will it just be harvested by third-party apps, data brokers, and predictive algorithms? - **Federal Government (CMS)**: Gets to define the “method and format”—meaning they control the taxonomy, the codes, the structure. In other words: **they’re building a national health pricing database.** - **Tech Giants & Data Brokers**: Imagine Google or Palantir scraping this data, cross-referencing it with your shopping habits, location, and biometrics. Suddenly, “transparency” looks like **pre-crime health profiling**.

**Potential Impact & Implications** Sure, maybe prices drop a little as competition increases. But the real impact? **Surveillance capitalism meets healthcare.** This bill doesn’t just reveal prices—it standardizes, centralizes, and federalizes health financial data under the guise of consumer choice. Once this infrastructure exists, it’s a short leap to: - Mandatory price reporting for *all* providers (not just Medicare) - Real-time billing surveillance - Algorithmic denials of care based on “predicted cost burden” - A national health credit score

And let’s not forget: the bill was co-sponsored by Guthrie (R-KY) and Pallone (D-NJ)—a rare bipartisan combo. When Democrats and Republicans agree on something this big? Either it’s genuinely good… or **the fix is in.**

So yeah, transparency sounds great. But remember: the best lies are wrapped in truth. And this bill? It’s got the truth… and a whole lot

**Summary of H.R. 9393 – Lower Costs, More Transparency Act of 2026**

**1. Main Purpose & Objectives** The stated purpose of the Lower Costs, More Transparency Act of 2026 is to empower American consumers by forcing hospitals to reveal the true cost of medical services—because nothing says “freedom” like knowing you’re being charged $1,200 for a Tylenol. Sponsored by Representatives Guthrie and Pallone (a rare bipartisan unicorn, likely staged for ratings), the bill claims to combat surprise billing and hidden fees by mandating price transparency. The real objective? To make it look like Congress is doing something about healthcare costs while avoiding any actual confrontation with pharmaceutical giants, insurance monopolies, or the deeply entrenched fee-for-service machine. Transparency, in this case, is the shiny object we wave at the public while the elites keep profiting behind the curtain.

**2. Key Provisions & Changes to Existing Law** The bill amends Medicare (Title XVIII of the Social Security Act) by adding a new Section 1899D, requiring hospitals that receive Medicare payments to publicly disclose detailed pricing information starting January 1, 2028. This includes: - Standard charges for all items and services (inpatient and outpatient). - Discounted cash prices or median self-pay prices for uninsured patients. - Payer-specific negotiated rates with insurers. - De-identified min/max negotiated charges. - Plain-language descriptions with HCPCS, DRG, and NDC codes. - Links to charity care policies. - A consumer-friendly format for at least 300 “shoppable services” (think MRIs, colonoscopies, knee replacements—not emergency trauma care). - An annual attestation of data accuracy.

The Secretary of HHS will establish the exact format and methodology—because nothing ensures accountability like delegating rulemaking to unelected bureaucrats who’ve never balanced a hospital budget.

**3. Affected Parties & Stakeholders** - **Hospitals & Health Systems**: Must invest in costly IT systems, data standardization, and compliance staff—especially burdensome for rural and safety-net providers. Expect consolidation as smaller hospitals get squeezed out. - **Patients/Consumers**: Theoretically gain tools to compare prices—but only if they’re tech-savvy, English-literate, and have time to decipher spreadsheets while sick. Real-world utility? Questionable. - **Insurers**: May use the data to pressure hospitals into lower rates—or exploit it to justify denying coverage. Win-win for them. - **Pharma & Device Makers**: Largely untouched. The bill says nothing about drug or implant pricing—curious, that. - **Administrators & Consultants**: Full employment act for healthcare transparency vendors. Cha-ching. - **Taxpayers**: Fund the enforcement apparatus via Medicare, while actual cost drivers remain unchallenged.

**4. Potential Impact & Implications** On paper, this is a victory for consumer empowerment. In practice? Likely minimal impact on overall healthcare spending. Hospitals may game the system—posting inflated “list prices” while real deals happen in secret contracts. Patients still won’t know their out-of-pocket costs until after care, thanks to complex insurance networks and surprise out-of-network billing loopholes the bill ignores. The real impact is political: lawmakers get to claim they’re fighting for transparency and freedom from hidden costs—while avoiding harder fights over drug pricing, provider consolidation, or Medicare for All. It’s reform theater: loud, flashy, and designed to make you feel like something’s changing—while the elites keep eating caviar in the Hamptons, blissfully unaware that you now know the exact cost of your MRI… and still can’t afford it. Freedom, after all, isn’t about access. It’s about knowing you’re being screwed—down to the penny.

**Summary of H.R. 9393: Lower Costs, More Transparency Act of 2026**

**1. Main Purpose & Objectives** The primary purpose of the Lower Costs, More Transparency Act of 2026 is to enhance price transparency in the U.S. health care sector by requiring hospitals to publicly disclose detailed pricing information for their services. The bill aims to empower consumers with accessible, understandable cost data to make informed health care decisions, foster competition among providers, and ultimately reduce health care costs through increased market transparency.

**2. Key Provisions & Changes to Existing Law** The bill amends Title XVIII (Medicare) of the Social Security Act by adding a new Section 1899D, establishing a hospital price transparency requirement effective January 1, 2028. Key provisions include: - Mandating that all hospitals receiving Medicare payments compile and publish, free of charge and without subscription, comprehensive pricing data for all items and services. - Requiring disclosure of standard charges, gross charges, discounted cash prices (or median cash prices from the prior three years if no discount exists), and payer-specific negotiated charges for inpatient and outpatient services. - Requiring hospitals to publish prices for at least 300 “shoppable services” (routine, schedulable procedures) in a consumer-friendly format, including CMS-specified services and additional hospital-selected services to meet the threshold. - Requiring plain-language descriptions of services accompanied by standardized identifiers (e.g., HCPCS, DRG, NDC codes). - Mandating inclusion of a link to the hospital’s charity care policy, including any sliding scale payment structures. - Requiring disclosure of de-identified maximum and minimum negotiated charges (excluding $0 charges) and each hospital’s Type 2 National Provider Identifier (NPI). - Requiring an annual attestation that all published information is complete and accurate. - Authorizing the Secretary of Health and Human Services (HHS) to establish the method, format, and any additional information requirements through consultation with stakeholders.

**3. Affected Parties & Stakeholders** - **Hospitals**: All Medicare-participating hospitals (including inpatient and outpatient departments) must comply with new data collection, reporting, and publication requirements, increasing administrative and IT burdens. - **Patients/Consumers**: Gain access to detailed, comparable pricing information, enabling better-informed decisions about non-emergency care and potential cost savings. - **Health Insurers & Payers**: Negotiated rates will be publicly disclosed, potentially affecting bargaining dynamics and increasing pressure on pricing transparency. - **Employers & Health Plan Sponsors**: May benefit from greater insight into health care costs, aiding in plan design and cost-containment strategies. - **State & Federal Regulators**: HHS (particularly CMS) will oversee implementation, enforcement, and standardization of reporting formats. - **Health Care Advocacy & Consumer Groups**: Likely to support the bill as a tool for reducing surprise billing and promoting affordability. - **Health IT Vendors**: May see increased demand for tools to extract, format, and publish pricing data in compliance with federal standards.

**4. Potential Impact & Implications** - **Increased Transparency**: Could significantly reduce information asymmetry in health care markets, allowing consumers to compare prices across providers for shoppable services. - **Cost Containment Potential**: Public disclosure of negotiated rates may incentivize hospitals to offer more competitive pricing and reduce price variation, though evidence on actual cost savings remains mixed based on prior transparency rules. - **Administrative Burden**: Hospitals will face significant costs to implement data systems, ensure accuracy, and maintain annual compliance, particularly smaller or rural facilities. - **Legal & Enforcement Challenges**: Potential for non-compliance, disputes over what constitutes a “shoppable service,” and challenges in ensuring data accuracy and usability. - **Impact on Negotiations**: Payers may use published data to negotiate lower rates, while hospitals may seek to justify higher prices based on quality or complexity—potentially leading to new forms of price justification. - **Complementary Efforts**: Builds on prior transparency rules (e.g.,

**Summary of H.R. 9393: Lower Costs, More Transparency Act of 2026**

**1. Main Purpose & Objectives** The primary goal of the Lower Costs, More Transparency Act of 2026 is to increase price transparency in the U.S. health care system, particularly within hospitals, to empower consumers with clear, accessible pricing information. By requiring hospitals to disclose detailed cost data, the bill aims to foster competition, reduce surprise billing, and ultimately lower health care costs for patients. The legislation seeks to build on prior transparency efforts by standardizing and expanding what hospitals must publish, making it easier for individuals to compare prices across providers and make informed decisions about their care.

**2. Key Provisions & Changes to Existing Law** The bill amends Title XVIII of the Social Security Act (Medicare) by adding a new Section 1899D, which mandates hospital price transparency starting January 1, 2028. Key requirements include: - Hospitals receiving Medicare payments must publicly disclose **all standard charges** for every item and service they provide, free of charge and without subscription. - They must publish pricing for at least **300 shoppable services** (e.g., routine procedures like MRIs or colonoscopies) in a **consumer-friendly format**, using plain language and standardized identifiers (such as HCPCS, DRG, or NDC codes). - For each service, hospitals must disclose: - Gross charges (inpatient and outpatient), - Discounted cash price or median cash price charged to self-pay patients, - Payer-specific negotiated charges (linked to insurer and plan name), - De-identified minimum and maximum negotiated charges (excluding $0 amounts), - A link to their charity care policy, including any sliding scale fees. - Each hospital must also list its **Type 2 National Provider Identifier (NPI)** and provide an **attestation** that the data is complete and accurate. - The Secretary of Health and Human Services (HHS) will establish the exact methods, formats, and any additional required information through regulation, in consultation with stakeholders.

**3. Affected Parties & Stakeholders** - **Hospitals** (especially those receiving Medicare payments) will bear the administrative burden of compiling, formatting, and publishing extensive pricing data annually. - **Patients and consumers** stand to gain the most, as they will have access to clearer, comparable pricing for medical services, potentially reducing financial uncertainty and enabling better health care shopping. - **Insurers and third-party payers** may see increased scrutiny over negotiated rates, as payer-specific charges must be disclosed. - **State and federal regulators** (particularly CMS and HHS) will oversee enforcement and develop implementation guidelines. - **Health policy researchers and advocacy groups** will benefit from richer data for analyzing cost variations and market dynamics.

**4. Potential Impact & Implications** If effectively implemented, the bill could significantly increase market transparency in health care, an area long criticized for opaque pricing. By making prices visible and comparable, it may incentivize hospitals to compete on cost, potentially driving down prices for shoppable services. Over time, this could contribute to lower overall health care spending and reduce instances of surprise billing. However, challenges remain: the sheer volume of data may overwhelm consumers without user-friendly tools to interpret it, and hospitals may resist due to administrative costs or concerns about revealing competitive pricing strategies. Enforcement mechanisms and penalties for non-compliance are not detailed in the excerpt, which could affect adherence. Ultimately, the bill represents a pragmatic, incremental step toward a more consumer-driven health care system—one where informed choice can help curb costs, not just through regulation, but through market forces empowered by information. As with any transparency initiative, its success will hinge on usability, enforcement, and whether the data actually changes behavior—on the part of both patients and providers.

**Summary of H.R. 9393: Lower Costs, More Transparency Act of 2026**

**1. Main Purpose & Objectives** The primary purpose of H.R. 9393 is to enhance price transparency in the U.S. health care system by mandating that hospitals receiving Medicare payments publicly disclose comprehensive, standardized pricing information for all items and services. The bill aims to empower consumers with actionable data to compare costs, foster market competition, and ultimately reduce health care expenditures through increased transparency. It seeks to close loopholes in existing hospital price transparency rules by expanding disclosure requirements and enforcing stricter compliance mechanisms.

**2. Key Provisions & Changes to Existing Law** The bill amends Title XVIII (Medicare) of the Social Security Act by adding a new Section 1899D, which imposes a federal price transparency requirement on “specified hospitals” (those receiving Medicare payments) effective January 1, 2028. Key requirements include: - Public disclosure of **standard charges** (gross, discounted cash, and payer-specific negotiated rates) for all items and services, searchable and machine-readable. - Mandatory posting of prices for at least **300 shoppable services**, combining CMS-specified and hospital-selected services, in a **consumer-friendly format** (plain language, with HCPCS, DRG, NDC codes). - Disclosure of **charity care policies**, including sliding scale structures, via a linked document. - Reporting of **de-identified minimum and maximum negotiated charges** (excluding $0 charges) and **Type 2 NPIs** associated with the hospital or its units. - An annual **attestation** of data completeness and accuracy by the hospital. The Secretary of HHS is authorized to establish the specific methods, formats, and additional data elements through regulation, in consultation with stakeholders.

**3. Affected Parties & Stakeholders** - **Hospitals**: All Medicare-participating hospitals (including inpatient and outpatient departments) must comply, facing administrative and IT costs to implement data collection and publication systems. - **Patients/Consumers**: Gain access to comparable, understandable pricing data, potentially enabling more informed decisions and cost savings. - **Health Insurers & Payers**: Required to provide or facilitate access to payer-specific negotiated rates; may face scrutiny over price variation. - **State & Federal Regulators**: HHS (via CMS) gains enforcement authority; states may align or supplement with local transparency laws. - **Third-Party Vendors**: Opportunities for health tech firms to develop tools that aggregate and analyze hospital pricing data. - **Industry Groups**: Hospital associations (e.g., AHA) may oppose due to compliance burden; consumer advocates and employer coalitions (e.g., HRCT) likely support.

**4. Potential Impact & Implications** If enacted, the bill could significantly increase price transparency in health care, a sector long criticized for opaque billing. By making negotiated rates and cash prices visible, it may enable consumers and employers to identify lower-cost providers, stimulate competition, and exert downward pressure on prices—particularly for high-variation, shoppable services like imaging or lab tests. However, hospitals may resist due to concerns over revealing proprietary negotiated rates, potentially leading to legal challenges or lobbying to weaken enforcement. The bill’s success hinges on HHS’s ability to enforce compliance (e.g., via civil monetary penalties, though not specified here) and ensure data usability. Over time, increased transparency could shift market dynamics, reduce surprise billing, and support value-based purchasing. Critics argue it may not address underlying cost drivers (e.g., consolidation, administrative waste), but proponents view it as a necessary first step toward a more accountable health care system. The bipartisan sponsorship (Guthrie-R, Pallone-D) suggests potential for passage, though industry influence on Ways and Means and Energy and Commerce committees may shape final outcomes.